Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Plants (Basel) ; 13(6)2024 Mar 11.
Article in English | MEDLINE | ID: mdl-38592789

ABSTRACT

Medicinal plants have been a traditional remedy for numerous ailments for centuries. However, their usage is limited due to a lack of evidence-based studies elucidating their mechanisms of action. In some countries, they are still considered the first treatment due to their low cost, accessibility, and minor adverse effects. Mexico is in second place, after China, in inventoried plants for medicinal use. It has around 4000 species of medicinal plants; however, pharmacological studies have only been carried out in 5% of its entirety. The species of the Mexican arid zones, particularly in semi-desert areas, exhibit outstanding characteristics, as their adverse growing conditions (e.g., low rainfall and high temperatures) prompt these plants to produce interesting metabolites with diverse biological activities. This review explores medicinal plants belonging to the arid and semi-arid zones of Mexico, focusing on those that have stood out for their bioactive potential, such as Jatropha dioica, Turnera diffusa, Larrea tridentata, Opuntia ficus-indica, Flourensia cernua, Fouquieria splendes, and Prosopis glandulosa. Their extraction conditions, bioactive compounds, mechanisms of action, and biological efficacy are presented, with emphasis on their role in the treatment of respiratory diseases. Additionally, current research, novel applications, and perspectives concerning medicinal plants from these zones are also discussed.

3.
Plants (Basel) ; 10(10)2021 Sep 25.
Article in English | MEDLINE | ID: mdl-34685819

ABSTRACT

Plants from arid zones of Mexico are an interesting source of phytochemicals that exhibit a large number of biological properties. In this context, Rhus microphylla (Rm) and Myrtillocactus geometrizans (Mg) fruits have been used as folk remedies and to make traditional foods, respectively; however, studies on their composition and bioactivity are limited. Thus, the objective of this work was to evaluate the yields, phenolic composition, and bioactive properties (scavenging and reducing capacities, antiproliferative, and antifungal) of aqueous and hydroalcohol extracts of Rm and Mg fruits obtained by conventional agitation and ohmic heating (OH). The results showed that the Rm fruit extracts had the highest total phenolic content (TPC) values and the strongest scavenging and reducing capacities compared to those of Mg fruits, being characterized by the presence of gallic acid, while the composition of the Mg extracts varied with respect to the extraction conditions used. Regarding antifungal activity in vitro against two phytopathogenic fungi, Rhizopus stolonifer and Fusarium oxysporum, the hydroalcohol extracts obtained by conventional agitation of both plants (RmH-C and MgH-C) showed the best inhibitory effect, respectively. Interestingly, none of the extracts under study presented cytotoxicity against the noncancerous ARPE-19 cell line, while three extracts of Rm fruit exhibited a moderate antiproliferative activity against HeLa (cancerous) cell line. These findings reveal for the first time the potential of Rm and Mg fruits as a new source of bioactive compounds for future industrial applications.

4.
Health Promot Pract ; 22(6): 764-766, 2021 11.
Article in English | MEDLINE | ID: mdl-34229462

ABSTRACT

The Dignity Pack Project is a small-scale, crisis-oriented supply chain in Atlanta, Georgia, designed to meet the acute personal hygiene,menstrual health, and sexual health needs of people experiencing homelessness (PEH). It was organized in response to conditions during the COVID-19 pandemic that continue to illuminate and exacerbate the distinct and complex challenges PEH face when trying to meet their basic needs and maintain their health. In addition to being particularly vulnerable to COVID-19 due to underlying conditions, crowding, and shared living spaces, the pandemic makes it harder for PEH to access already scant resources. Specifically, shelters across the United States have experienced outbreaks and, as a result, have reduced capacity or closed completely. Social support organizations have paused or restricted services. Donations and volunteering have decreased due to economic conditions and social distancing requirements. This practice note describes how we integrated feedback from PEH at the outset of the Dignity Pack project-and continue to do so-enabling the development of a pragmatic, humanistic outreach model that responds to the evolving needs of PEH as pandemic conditions and the seasons change. We detail how we established complementary partnerships with local organizations and respond to critical insights provided by PEH. We offer lessons and recommendations driven by the needs and preferences of PEH.


Subject(s)
COVID-19 , Ill-Housed Persons , Sexual Health , Georgia , Humans , Hygiene , Pandemics , SARS-CoV-2 , United States
5.
PLoS One ; 13(7): e0200426, 2018.
Article in English | MEDLINE | ID: mdl-29979794

ABSTRACT

We have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.) reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i) bacterial biomass production, ii) LrS production, where the bacterial biomass was able to live but did not proliferate. Therefore, the simultaneous evaluation of the effect of different factors on the growth and LrS production was performed. Biomass production was found to be dependent mainly on culture medium, while LrS production with anti-inflammatory activity depended on culture conditions of the biomass such as pH, agitation and growth phase. The L. reuteri CRL 1098 biomass and LrS production in the optimized culture media designed for this work reduced the complete process cost by approximately 95%, respectively to laboratory scale cost.


Subject(s)
Anti-Infective Agents/metabolism , Limosilactobacillus reuteri/metabolism , Peptide Biosynthesis , Animals , Cell Culture Techniques/economics , Cost-Benefit Analysis , Culture Media/economics , Hydrogen-Ion Concentration , Inflammation/metabolism , Inflammation/microbiology , Limosilactobacillus reuteri/growth & development , Macrophages/metabolism , Macrophages/microbiology , Mice , Nitric Oxide/metabolism , RAW 264.7 Cells , Tumor Necrosis Factor-alpha/metabolism
6.
Food Chem Toxicol ; 50(12): 4310-5, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22975144

ABSTRACT

Ochratoxin A (OTA) is a widespread mycotoxin contaminating several food products which causes detrimental health effects. The ability of Lactobacillus reuteri CRL 1098 and Lactobacillus acidophilus CRL 1014 to prevent OTA effects on TNF-α and IL-10 production and apoptosis induction in human peripheral blood mononuclear cells (PBMC) was investigated. Membrane rafts participation in these responses was also evaluated. L. reuteri reduced by 29% the OTA inhibition of TNF-α production whereas L. acidophilus increased 8 times the TNF-α production by OTA treated-PBMC. Also, both bacteria reversed apoptosis induced by OTA by 32%. However, neither of the bacteria reversed the OTA inhibition on IL-10 production. On the other hand, the lactobacilli were less effective to reverse OTA effects on disrupted-rafts PBMC. This study shows that two lactobacilli strains can reduce some negative OTA effects, being membrane rafts integrity necessary to obtain better results. Also, the results highlight the potential capacity of some lactobacilli strains usually included in natural dietary components in milk-derived products and cereals feed, to reduce OTA toxicity once ingested by humans or animals.


Subject(s)
Apoptosis , Lactobacillus acidophilus/metabolism , Leukocytes, Mononuclear/drug effects , Limosilactobacillus reuteri/metabolism , Ochratoxins/toxicity , Adult , Cells, Cultured , Humans , Interleukin-10/metabolism , Leukocytes, Mononuclear/cytology , Probiotics/metabolism , Tumor Necrosis Factor-alpha/metabolism , Young Adult
7.
Int Immunopharmacol ; 14(4): 446-53, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22982041

ABSTRACT

The aim of the present study was to evaluate the capacity of Lactobacillus reuteri CRL1098 soluble factors (Lr-S) to modulate TNF-α production in peripheral blood mononuclear cells (PBMC) and to study lipid rafts participation in this response. PBMC treated with Lr-S showed a reduced production of TNF-α. In addition, Lr-S treatment activated ERK and p38 MAPK pathways in PBMC. Lipid rafts participation in the reduced production of TNF-α by PBMC induced by Lr-S was verified by lipid rafts disruption with methyl-ß-cyclodextrin and the reduction of the Src-tyrosine kinase Lck localization in rafts. Moreover, PBMC pre-treatment with Lck inhibitors blocked the effect of Lr-S on TNF-α production suggesting that activation and mobilization of Lck from lipid rafts would be involved in the modulatory effect of L. reuteri CRL1098. A secreted peptide of 5785 Da would be responsible of the modulatory effect of CRL1098 strain. This study demonstrated for the first time the lipid rafts participation in a response induced by a beneficial bacterium. Also, these results open new possibilities for investigating the molecular mechanisms involved in the interaction of probiotic bacterial extracellular compounds with immune cells.


Subject(s)
Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/physiology , Limosilactobacillus reuteri/metabolism , Membrane Microdomains , Tumor Necrosis Factor-alpha/metabolism , Adult , Cells, Cultured , Gene Expression Regulation/physiology , Humans , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Tumor Necrosis Factor-alpha/genetics , Young Adult
8.
Biochem Biophys Res Commun ; 347(1): 51-9, 2006 Aug 18.
Article in English | MEDLINE | ID: mdl-16824485

ABSTRACT

Cells exposed to simvastatin or to methyl-beta-cyclodextrin show reduced poliovirus infection, without alteration in virus binding or on the kinetics of genome entry, suggesting that the steps which are altered are those post uncoating and genome entry. Reduction of infection by cyclodextrin is reversed by increasing MOI whereas that produced by simvastatin treatment is not, suggesting that the effects on infection are not due to a reduction in cholesterol. The differences in the characteristics of inhibition can be explained by the differential effects of the compounds. Cyclodextrin inhibits the store-operated calcium channels, suggesting that reduction in infection is through translational inhibition. Simvastatin produces vesicles from internal membranes which cannot sustain viral RNA synthesis, reducing infection through reduced transcription. The results indicate that the impact on viral infection by the cholesterol-modifying agents is due to the cellular changes produced rather than due to disruption of the cholesterol-rich domains.


Subject(s)
Poliomyelitis/prevention & control , Poliomyelitis/virology , Poliovirus/drug effects , Poliovirus/physiology , Simvastatin/administration & dosage , Virus Replication/drug effects , beta-Cyclodextrins/administration & dosage , Antiviral Agents/administration & dosage , Cell Survival/drug effects , Dose-Response Relationship, Drug , HeLa Cells , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...